Tinengotinib, a novel fibroblast growth factor receptor (FGFR) inhibitor, is potent against resistance mutations in FGFR1/2/3

被引：1
|
作者：
Qiang, Xiaoyan
Yu, Qi
Fan, Jean
Wu, Frank
Sun, Caixia
Peng, Peng
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 08期
关键词：
D O I：
10.1158/1538-7445.AM2023-LB229
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB229
引用
收藏
页数：2
相关论文
共 50 条
  • [41] DIFFERENTIAL REGULATION OF FIBROBLAST GROWTH FACTOR-3 CONTROLS FGFR1:FGFR3 BALANCE IN CHONDROCYTES AFTER CARTILAGE INJURY
    Khan, S. N.
    Chanalaris, A.
    Vincent, T. L.
    OSTEOARTHRITIS AND CARTILAGE, 2016, 24 : S137 - S137
  • [42] Fibroblast growth factor receptor (FGFR) mutations in achondroplasia and related skeletal dysplasias
    Rasar, MA
    Cho, J
    Lunstrum, GP
    Horton, WA
    GROWTH PLATE, 2002, 54 : 175 - 181
  • [43] Characterization of FGFR1, FGFR2 and FGFR3 mutations in 45 Brazilian patients with craniosynostosis.
    Passos-Bueno, MR
    Sertié, AL
    Richieri-Costa, A
    Alonso, LG
    Zatz, M
    Alonson, N
    Brunoni, D
    Ribeiro, SFM
    Cavalheiro, S
    AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (04) : A342 - A342
  • [44] Efficacy of futibatinib, an irreversible fibroblast growth factor receptor (FGFR) inhibitor, in breast cancer models with FGFR alterations
    Saridogan, Turcin
    Akcakanat, Argun
    Zhao, Ming
    Evans, Kurt W.
    Yuca, Erkan
    Scott, Stephen
    Kirby, Bryce P.
    Zheng, Xiaofeng
    Damodaran, Senthil
    Meric-Bernstam, Funda
    CANCER RESEARCH, 2022, 82 (04)
  • [45] Prevalence of fibroblast growth factor receptor 1 (FGFR1) amplification in squamous cell carcinomas of the head and neck
    Till Sebastian Clauditz
    Arne Böttcher
    Henning Hanken
    Kerstin Borgmann
    Guido Sauter
    Waldemar Wilczak
    Tobias Grob
    Adrian Münscher
    Journal of Cancer Research and Clinical Oncology, 2018, 144 : 53 - 61
  • [46] Clinical outcomes of myeloid/lymphoid neoplasms with fibroblast growth factor receptor-1 (FGFR1) rearrangement
    Umino, Kento
    Fujiwara, Shin-ichiro
    Ikeda, Takashi
    Toda, Yumiko
    Ito, Shoko
    Mashima, Kiyomi
    Minakata, Daisuke
    Nakano, Hirofumi
    Yamasaki, Ryoko
    Kawasaki, Yasufumi
    Sugimoto, Miyuki
    Yamamoto, Chihiro
    Ashizawa, Masahiro
    Hatano, Kaoru
    Sato, Kazuya
    Oh, Iekuni
    Ohmine, Ken
    Muroi, Kazuo
    Kanda, Yoshinobu
    HEMATOLOGY, 2018, 23 (08) : 470 - 477
  • [47] Hypogonadotropic Hypogonadism due to Novel FGFR1 Mutations
    Akkus, Gamze
    Kotan, Leman Damla
    Durmaz, Erdem
    Mengen, Eda
    Turan, Ihsan
    Ulubay, Ayca
    Gurbuz, Fatih
    Yuksel, Bilgin
    Tetiker, Tamer
    Topaloglu, A. Kemal
    JOURNAL OF CLINICAL RESEARCH IN PEDIATRIC ENDOCRINOLOGY, 2017, 9 (02) : 95 - 100
  • [48] Prognostic value of Fibroblast Growth Factor Receptor (FGFR) 1 gene amplification and FGFR2/FGFR3 driver-mutations in patients with Squamous Cell Carcinoma (SCC) of the lung
    Flockerzi, F.
    Holleczek, B.
    Langer, F.
    Roggia, C.
    Schoepe, J.
    Bohle, R. M.
    VIRCHOWS ARCHIV, 2016, 469 : S37 - S37
  • [49] The resistance mechanism of FGFR2 amplified gastric cancer cells against AZD4547, a fibroblast growth factor receptor inhibitor
    Lee, S. Y.
    Jeong, Y.
    Na, Y.
    Kim, J. L.
    Lee, D. H.
    Oh, S. C.
    ANNALS OF ONCOLOGY, 2016, 27
  • [50] Discovery of BW710 as a potent, selective and orally bioavailable fibroblast growth factor receptor 2 (FGFR2) inhibitor
    Yang, Bowen
    Xun, Qiuju
    Tian, Yuan
    Li, Huiqiong
    Wu, Pinglian
    Zhou, Yang
    Chang, Shaohua
    Wang, Zhen
    Ding, Ke
    Ma, Dawei
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2025, 287
12345